Realization of a part of clinical trial called A multicenter, randomized, double-blinded, parallel-group, placebocontrolled study to assess the efficacy and safety of skeletal muscle-derived cell implantation in female patients with stress urinary incontinence (SUI) of moderate severity (Grade 2 and Grade 3) in female patients